Products

Personalized Therapy Comfort Settings (PTCS)
ResMed
Clinical Decision Support & Reference
ResMed's Smart Comfort (Personalized Therapy Comfort Settings - PTCS) is an FDA-cleared, AI-enabled digital tool that recommends personalized comfort settings for CPAP therapy, designed to enhance adherence for new users of AirSense 11 devices.

See all 1 product →

About ResMed

ResMed is a global leader in digital health technology, specializing in cloud-connected medical devices and software solutions for sleep and respiratory disorders. The company’s core offerings include devices and masks for treating sleep apnea, such as CPAP, APAP, and VPAP machines, as well as ventilators for chronic obstructive pulmonary disease (COPD) and other respiratory conditions.

For physicians, ResMed’s AI-powered digital health solutions are designed to enhance therapy performance, streamline patient care, and provide practical insights from complex health data. For instance, the FDA-cleared Smart Comfort feature utilizes AI and machine learning to recommend personalized comfort settings for CPAP therapy, aiming to improve patient adherence and reduce the need for manual adjustments by clinicians. ResMed also offers a generative AI assistant, DAWN, within its myAir consumer app, which provides patients with personalized answers to common sleep and therapy questions, thereby supporting patient engagement and confidence in their care. The company’s comprehensive out-of-hospital software platforms further support healthcare professionals and caregivers in delivering personalized, data-driven care, ultimately aiming to improve patient outcomes and reduce healthcare costs.

What Physicians Need to Know

Specialization in Sleep & Respiratory Care AI
ResMed specializes in AI-enabled solutions for sleep and breathing disorders, particularly obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and insomnia. Their focus is on personalizing therapy and improving adherence for patients using devices like CPAP machines.
FDA-Cleared AI Medical Device
ResMed's 'Smart Comfort' (officially Personalized Therapy Comfort Settings) is the first FDA-cleared AI-enabled medical device that recommends personalized comfort settings for CPAP therapy. This feature, debuting in 2026, adjusts non-prescription comfort settings based on real sleep data and machine learning.
Data-Driven Personalization
Smart Comfort leverages proprietary machine-learning algorithms trained on over 100 million nights of de-identified, real-world sleep data. It considers factors like age, gender, and Apnea-Hypopnea Index (AHI) to suggest individualized settings for ramp speed, start pressure, and exhalation relief.
Extensive Data Ecosystem
ResMed boasts a massive digital health data set, including 28 million patients in its AirView software ecosystem, 26 million cloud-connected medical devices, and 20 billion nights of sleep and breathing health data across 140 countries. This extensive data forms the backbone for their AI and machine learning initiatives.
Generative AI for Patient Support
ResMed has introduced 'Dawn,' a generative AI digital concierge and sleep health assistant. Dawn provides 24/7 access to information about sleep health, ResMed products, and CPAP therapy support, aiming to enhance patient engagement and education.
Cloud-Connected Ecosystem
ResMed's AI-driven digital platform seamlessly integrates cloud-connected devices and digital tools, such as the myAir app and AirSense 11 devices, to enhance provider efficiency and enable more personalized care. This connected ecosystem aims to streamline setup and ongoing therapy management.
Physician Tip

For physicians, ResMed's AI-enabled tools, particularly Smart Comfort, can significantly reduce the need for manual adjustments of CPAP comfort settings, allowing more time to focus on clinical care and decision-making. The personalized settings, driven by extensive real-world data, can lead to higher patient engagement and adherence to CPAP therapy, especially for new users. The AirView platform, with embedded AI models, can flag patients at risk of therapy non-adherence, providing earlier insights for intervention. Additionally, the generative AI assistant, Dawn, can serve as a valuable resource for patients, answering common questions and providing support, which can indirectly reduce physician workload related to routine inquiries. ResMed's focus on a 'care delivered in the home' model, supported by AI and connected devices, facilitates remote patient monitoring and personalized therapy, which is particularly relevant for managing chronic conditions.

ResMed's technology stack primarily utilizes Amazon Web Services (AWS) for its data, AI, and machine learning backbone, including the Intelligence Health Signals (IHS) platform built on AWS. They leverage Amazon SageMaker for their AI/ML platform and AWS Glue for connecting their data lake to SageMaker. Snowflake is also a key vendor for ResMed. Their solutions are designed for seamless integration within ResMed's connected ecosystem, including the myAir app and compatible devices like the AirSense 11. ResMed is also working on integrating AirView with Electronic Health Record (EHR) systems to facilitate the exchange of patient data with healthcare providers. The myAir app integrates with Apple and Android smartwatches, further expanding their digital health ecosystem.

Products by ResMed

1 product in the directory

Personalized Therapy Comfort Settings (PTCS)
ResMed
Clinical Decision Support & Reference
ResMed's Smart Comfort (Personalized Therapy Comfort Settings - PTCS) is an FDA-cleared, AI-enabled digital tool that recommends personalized comfort settings for CPAP therapy, designed to enhance adherence for new users of AirSense 11 devices.

What the Web Says

ResMed generally receives positive feedback for its CPAP machines and masks, with many users reporting significant improvements in sleep quality and overall health. However, some product-related complaints include noise issues with certain models and mask discomfort or leakage. As an employer, ResMed is often praised for its company culture, management, and benefits, though some employees express concerns about work-life balance, opportunities for advancement, and management in specific departments.

Overall: Mixed

Strengths

  • Radically improved sleep quality and overall health with CPAP machines.
  • Quiet operation of CPAP machines.
  • Effective humidification system with heated tubing support.
  • Superior detailed data reporting for compliance.
  • Reliable machines with long motor life.
  • Positive company culture, good management, and benefits.

Limitations

  • Some CPAP machine models can be noisy.
  • Mask discomfort, leaks, or issues with fit.
  • Masks are considered consumable items and can be expensive.
  • Occasional issues with machines self-adjusting to breathing patterns.
  • Concerns about work-life balance and long hours in some departments.
  • Limited opportunities for growth and advancement in certain roles.

Based on reviews from: Reddit, Comparably, Indeed.com, Zippia, Oxygen Concentrator Store, Quora, ProductReview.com.au, Trustpilot

Last updated: 2026-10-26

Videos

News, demos, and interviews about ResMed.

Loading videos...

Videos load interactively. If none appear, search YouTube for ResMed →

View all on YouTube

Press & Coverage

The CPAP Shop
ResMed Receives FDA Clearance For AI-Enabled Features: What Does This Mean for You as a CPAP User?
ResMed has received FDA clearance for its AI-enabled 'Smart Comfort' feature, designed to personalize CPAP comfort settings based on user sleep data and machine learning. This aims to help CPAP users initiate and maintain therapy more comfortably.
2026-03
Sleep Review
FDA Clears AI-powered Smart Comfort to Personalize CPAP Comfort Settings
The FDA granted 510(k) clearance for ResMed's AI-enabled medical device, Smart Comfort, which recommends personalized comfort settings for CPAP therapy. It will launch in early 2026 in a limited beta for new myAir users with an AirSense 11 device.
2025-12
ResMed Newsroom
ResMed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
ResMed announced the U.S. launch of its AirTouch F40, a new full face fabric CPAP mask designed for enhanced comfort and choice in obstructive sleep apnea therapy. This mask aims to improve long-term adherence by offering a soft, breathable fabric cushion.
2026-10
Medtech Insight
ResMed Partners With Consumer Sleep-Tech Firm Eight Sleep, Launches New Fabric Mask
ResMed is partnering with Eight Sleep to connect users showing signs of disturbed sleep to sleep apnea evaluations, and also plans to launch its AirTouch F40 fabric mask.
2026-10
ResMed Newsroom
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
A landmark meta-analysis published in The Lancet Respiratory Medicine, supported by ResMed, found that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea. The study analyzed data from over 1 million patients, showing a 37% lower risk of all-cause mortality and a 55% lower risk of cardiovascular-related death.
2025-03
ResMed Investor Relations
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
ResMed announced strong fourth-quarter and full fiscal year 2026 results, with revenue increasing 9% and 10% respectively. The company also declared a 10% increase in its quarterly cash dividend and announced an agreement to sell its MatrixCare business.
2026-08
FDA
ResMed Ltd. Recalls Continuous Positive Airway Pressure (CPAP) Masks with Magnets due to Possible Magnetic Interference with Certain Medical Devices
ResMed issued a recall for certain CPAP masks with magnets due to potential magnetic interference with medical devices, which could cause serious harm or death. The recall updates labels with more warnings and information for safe usage.
2024-01
GrantForward
ResMed Foundation - Clinical Research Proposals
The ResMed Foundation provides grants for clinical research proposals focused on sleep-disordered breathing and sleep health, with grants typically limited to about $250,000 over the study term.
2013-12

Frequently Asked Questions

ResMed utilizes AI in its connected devices and digital health solutions to personalize therapy, predict patient adherence, and identify potential issues early. This leads to improved patient outcomes through optimized treatment, reduced administrative burden for clinicians, and more efficient resource allocation within healthcare systems.
ResMed prioritizes data privacy and security through robust encryption, access controls, and adherence to global regulations like HIPAA and GDPR. They implement comprehensive security protocols and conduct regular audits to protect sensitive patient information and maintain compliance with evolving healthcare data standards.
ResMed's pricing for AI-driven solutions often involves a combination of device costs and subscription fees for digital health platforms and data analytics services. They offer flexible models designed to integrate with various healthcare IT systems, and detailed pricing can be discussed with a ResMed representative to tailor solutions to specific organizational needs.
ResMed provides comprehensive technical support and clinical training, including on-site education, online modules, and dedicated customer service teams. This ensures healthcare professionals are proficient in using their AI-enhanced products, optimizing patient care, and troubleshooting any technical issues effectively.
ResMed collaborates with various healthcare organizations, technology companies, and research institutions to advance its AI capabilities and expand its product ecosystem. These partnerships foster innovation, improve interoperability with other healthcare systems, and broaden the reach of their solutions to a wider patient population.
ResMed maintains a strong commitment to research and development, continuously investing in AI innovation to address evolving healthcare needs. Their long-term strategy involves ongoing collaboration with clinical experts, leveraging real-world data, and adapting their AI algorithms to ensure their solutions remain at the forefront of sleep and respiratory care.

Investors

Who's funded ResMed.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.